Literature DB >> 9654082

Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E.

T Kageyama1.   

Abstract

Molecular cloning of a cDNA for a pepsin inhibitor in the round worm, Ascaris suum, was achieved. The ORF was found to encode a 20-residue potential signal peptide and a 149-residue inhibitor moiety. Northern analysis showed the mRNA for the inhibitor to be expressed in the body wall and not in the viscera. To obtain the active inhibitor, we constructed a yeast expression vector, pYES2API, containing the inducible galactosidase promoter and a DNA fragment encoding a fusion protein of the yeast alpha-factor leader and the Ascaris pepsin inhibitor. The active inhibitor was secreted in the culture medium, the yield being approximately 3 mg x l(-1) x day(-1), and purified by a two-step procedure that included HPLC. The inhibitor inactivated pepsin A and cathepsin E almost completely at amounts equimolar with the enzymes, but was 100-fold less effective against pepsin C and did not act on cathepsin D and renin. Ki values for the inhibition of pepsin A and cathepsin E were in the nanomolar range below pH 5. Since the inhibitor activity was lost by modification of specific Lys residues, including Lys110, an electrostatic interaction between these Lys residues and Asp/Glu residues of pepsin A or cathepsin E was thought to be essential for the inhibition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654082     DOI: 10.1046/j.1432-1327.1998.2530804.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Immune responses to recombinant Brugia malayi pepsin inhibitor homolog (Bm-33) in patients with human lymphatic filariaisis.

Authors:  N S A Krushna; C Shiny; G Manokaran; S Elango; S Babu; R B Narayanan
Journal:  Parasitol Res       Date:  2010-10-07       Impact factor: 2.289

2.  Recombinant Brugia malayi pepsin inhibitor (rBm33) induced monocyte function and absence of apoptotic cell death: an in vitro study.

Authors:  Kirthika Sreenivas; Kamalakannan Vijayan; Subash Babu; Rangarajan Badri Narayanan
Journal:  Microb Pathog       Date:  2012-03-30       Impact factor: 3.738

3.  Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite.

Authors:  Laura Sanglas; Francesc X Aviles; Robert Huber; F Xavier Gomis-Rüth; Joan L Arolas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

4.  Characterization of a novel aspartyl protease inhibitor from Haemonchus contortus.

Authors:  Baojie Li; Javaid Ali Gadahi; Wenxiang Gao; Zhenchao Zhang; Muhammad Ehsan; Lixin Xu; Xiaokai Song; Xiangrui Li; Ruofeng Yan
Journal:  Parasit Vectors       Date:  2017-04-19       Impact factor: 3.876

5.  A structural biology approach to understand human lymphatic filarial infection.

Authors:  Raghavendra Sashi Krishna Nagampalli; Krishnasamy Gunasekaran; Rangarajan Badri Narayanan; Angela Peters; Rajagopalan Bhaskaran
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.